How does onychomycosis prevalence differ in immunocompromised populations, what percentage of transplant or cancer patients are affected, and how do their outcomes compare with healthy individuals?
How does onychomycosis prevalence differ in immunocompromised populations, what percentage of transplant or cancer patients are […]